This is PrecisionLife
Chronic diseases affect billions of patient lives and account for over 80% of healthcare spendin.
We are the first and only company able to identify the causal mechanisms of complex disease biology to now predict, treat, and prevent chronic diseases.
From concept to clinic
60+
Diseases in which we have unique mechanistic insights
80%
We're reducing the burden of diseases that are responsible for 80% of healthcare costs
5.4B
Our precision medicine solutions have the potential to benefit over 5 billion patient lives
Understanding disease biology better
Chronic diseases present the most complex, prevalent, and costly challenge in healthcare.
We’re creating a new generation of better, more accurate diagnostic, prognostic, and therapy selection tools to intervene earlier with greater success.
And transforming the ability to develop better, more personalized medicines faster for people living with complex diseases.
Stratifying patient populations
We find more signal in patient data than anyone else.
Our high-resolution patient stratification identifies subgroups of patients with similar disease drivers and treatment responses, to make precision medicine possible in chronic diseases.
We discover new drug targets, enrich clinical trials, find drug repositioning opportunities, and inform better diagnosis and the prescription of more effective therapies.
Driving precision medicine
Our AI-led precision medicine platform, powered by our unique combinatorial analytics, stratifies patient populations at the highest resolution, finding all the mechanistic drivers of disease for subgroups of patients.
With these insights we are:
✔ Discovering novel drug targets and leads for unmet medical needs
✔ Identifying drug repositioning candidates for patient subgroups
✔ Enriching clinical trials and rescuing shelved programs
✔ Designing more accurate diagnostic and clinical decision support tools
✔ Predicting and preventing chronic disease in patients